Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances

May 25, 2012

(Medical Xpress) -- The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by a National Institutes of Health research network.

PCOS is a disorder in which the ovaries, and sometimes the adrenal glands, produce excess amounts of hormones known as androgens. Women with PCOS typically have menstrual irregularities and may have difficulty getting pregnant. for the condition typically involves ovulation induction — drug treatment to stimulate the release of an egg. Before ovulation induction, physicians may administer a single course of progestin. Progestin leads to a thickening in the lining of the uterus. Without continuous administration of progestin to maintain the thickening, the uterine lining is sloughed off, and bleeding begins. The idea behind the treatment is to simulate the bleeding that occurs at the beginning of the monthly menstrual cycle.

The researchers found, however, that women who skipped the progestin treatment before receiving fertility drugs were four times more likely to conceive than were women given progestin. Ultimately, 20 percent of the women who did not receive progestin gave birth, compared with about 5 percent of the women who received progestin.

"Our results indicate that a treatment with progestin before ovulation induction is counterproductive in helping women with PCOS achieve pregnancy," said Esther Eisenberg, M.D., of the Reproductive Sciences Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), one of the study authors.

The study was conducted by Michael P. Diamond, M.D., of Wayne State University in Detroit, Richard S. Legro, M.D., of the Penn State College of Medicine in Hershey, and researchers at 16 institutions in the NICHD Cooperative Reproductive Medicine Network (RMN).

The study was published online in Obstetrics and Gynecology.

The study was an analysis of data from a 2007 RMN study comparing two fertility treatments for women with PCOS: the standard drug therapy clomiphene, which stimulates ovulation, and the diabetes treatment drug metformin.

Women with PCOS frequently experience insulin resistance, a condition in which the body fails to use insulin properly. Studies have shown that drugs such as metformin, which make the body more sensitive to insulin, can increase ovulation rates in women with PCOS. However, the 2007 study found that women taking metformin alone were less likely to get pregnant and give birth than those receiving either clomiphene or a combination of clomiphene and metformin.

The current analysis of the data from the 2007 study compared the effectiveness of ovulation induction combined with advance progestin treatment to that of ovulation induction alone.

The analysis revealed that when women had a spontaneous menstrual cycle, 72 percent ovulated again the following month. About 5 percent of these women were able to conceive.

However, many of the women pursuing fertility treatment failed to ovulate in a given month. Women who received a dose of progestin, followed by ovulation induction, ovulated in 30 percent of cases. Nearly 7 percent of these women conceived.

Women who did not receive progestin ovulated 27 percent of the time, but nearly 28 percent of these were able to get pregnant.

The study authors noted that simulating the menstrual cycle is also used in treatments for other kinds of infertility.

Explore further: Diabetes drug may prevent or delay development of polycystic ovary syndrome

Related Stories

Diabetes drug may prevent or delay development of polycystic ovary syndrome

June 29, 2011
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development ...

Women with PCOS have family heart disease link

October 5, 2011
A new study from the University of Adelaide shows the parents of women with polycystic ovary syndrome (PCOS) are more likely to have some form of cardiovascular disease.

Polycystic ovary syndrome and cardiovascular disease

October 14, 2011
One in 15 women of childbearing age is diagnosed with a disorder commonly referred to as polycystic ovary syndrome (PCOS). The condition is one of the most common causes of women not ovulating and thus causes difficulty in ...

Recommended for you

Hope for couples suffering IVF miscarriage

September 20, 2017
Women who miscarry during their first full round of IVF are more likely to have a baby after further treatment than women who don't get pregnant at all.

Does mother's mental health affect pregnancy?

September 13, 2017
(HealthDay)—Three common mental health disorders—depression, panic disorder and generalized anxiety disorder—pose no serious threat to pregnant women or the health of their babies, a new study finds.

Preeclampsia may boost heart disease risk by altering blood vessels

September 12, 2017
Preeclampsia may permanently change the blood vessels of women who experience the condition during pregnancy, boosting their lifelong risk for cardiovascular disease, according to Penn State researchers.

Discovery of genes linked to preterm birth in landmark study

September 6, 2017
A massive DNA analysis of pregnant women has identified six gene regions that influence the length of pregnancy and the timing of birth. The findings, published today in the New England Journal of Medicine, may lead to new ...

Older wombs linked to complications in pregnant mice

September 5, 2017
Deciding to start a family later in life could be about more than just the age of your eggs. A new study in mice suggests the age of a mother's womb may also have a part to play. This work, led by Dr Myriam Hemberger at the ...

Study suggests simple way to predict preterm births

September 4, 2017
Up to 18 percent of babies born worldwide arrive before they are full-term, defined as 37 weeks of gestation. About 1 million of those babies do not survive, and those who do can face developmental problems such as impaired ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.